Joseph Petroziello

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Joseph Petroziello

Unternehmen	Position	Beginn	Ende
BRAINSTORM CELL THERAPEUTICS INC.	Public Communications Contact	28.06.2018	01.04.2020
JUNO THERAPEUTICS INC	Corporate Officer/Principal	01.01.2014	01.01.2018
SEAGEN INC.	Corporate Officer/Principal	01.01.2000	-

University of Scranton

Graduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Public Communications Contact	1
Graduate Degree	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
BRAINSTORM CELL THERAPEUTICS INC.	Health Technology

Private Unternehmen	2
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA.	Health Technology

Private Unternehmen

Health Technology